Evidence map›Paper›PMID 37681892›Full record

ArticleCells2023

Physical Properties and Cellular Metabolic Characteristics of 3D Spheroids Are Possible Definitive Indices for the Biological Nature of Cancer-Associated Fibroblasts.

Nami Nishikiori, Kohichi Takada, Tatsuya Sato, Sho Miyamoto, Megumi Watanabe, Yui Hirakawa, Shohei Sekiguchi, Masato Furuhashi, Akira Yorozu, Kenichi Takano and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Nami NishikioriDepartment of Ophthalmology, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.ORCID 0009-0001-9894-8523
Kohichi TakadaDepartment of Medical Oncology, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.ORCID 0000-0002-1393-9442
Tatsuya SatoDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.ORCID 0000-0001-7876-1772
Sho MiyamotoDepartment of Oral Surgery, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.ORCID 0000-0001-9573-1161
Megumi WatanabeDepartment of Ophthalmology, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.ORCID 0000-0002-8026-6532
Yui HirakawaDepartment of Oral Surgery, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.
Shohei SekiguchiDepartment of Oral Surgery, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.
Masato FuruhashiDepartment of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.ORCID 0000-0002-0145-3541
Akira YorozuDepartment of Molecular Biology, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.
Kenichi TakanoDepartment of Otolaryngology, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.ORCID 0000-0001-8706-6384
Akihiro MiyazakiDepartment of Oral Surgery, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.ORCID 0000-0003-3290-6205
Hiromu SuzukiDepartment of Molecular Biology, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.ORCID 0000-0001-9635-3238
Hiroshi OhguroDepartment of Ophthalmology, Sapporo Medical University, S1W17, Chuo-ku, Spporo 060-8556, Japan.
Sapporo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current study's objective was to elucidate some currently unknown biological indicators to evaluate the biological nature of cancer-associated fibroblasts (CAFs). For this purpose, four different CAFs, CAFS1, CAFS2, SCC17F and MO-1000, were established using surgical specimens from oral squamous cell carcinomas (OSCC) with different clinical malignant stages (CAFS1 and CAFS2, T2N0M0, stage II; SCC17F and MO-1000, T4aN2bM0, stage IVA). Fibroblasts unrelated to cancer (non-CAFs) were also prepared and used as controls. Initially, confirmation that these four fibroblasts were indeed CAFs was obtained by their mRNA expression using positive and negative markers for the CAF or fibroblasts. To elucidate possible unknown biological indicators, these fibroblasts were subjected to a cellular metabolic analysis by a Seahorse bioanalyzer, in conjugation with 3D spheroid cultures of the cells and co-cultures with a pancreas ductal carcinoma cell line, MIA PaCa-2. The mitochondrial and glycolytic functions of human orbital fibroblasts (HOF) were nearly identical to those of Graves'-disease-related HOF (GOF). In contrast, the characteristics of the metabolic functions of these four CAFs were different from those of human conjunctival fibroblasts (HconF), a representative non-CAF. It is particularly noteworthy that CAFS1 and CAFS2 showed markedly reduced ratios for the rate of oxygen consumption to the extracellular acidification rate, suggesting that glycolysis was enhanced compared to mitochondrial respiration. Similarly, the physical aspects, their appearance and stiffness, of their 3D spheroids and fibroblasts that were induced effects based on the cellular metabolic functions of MIA PaCa-2 were also different between CAFs and non-CAFs, and their levels for CAFS1 or SCC17F were similar to those for CAFS2 or MO-1000 cells, respectively. The findings reported herein indicate that cellular metabolic functions and the physical characteristics of these types of 3D spheroids may be valuable and useful indicators for estimating potential biological diversity among various CAFs.

Indexed as

Cancer-Associated FibroblastsPancreatic NeoplasmsCerebellumDiabetes MellitusFaciesFetal Growth RetardationFibroblastsHumansOxygen Consumption3D spheroid culturecancer-associated fibroblastoral squamous carcinomaSeahorse bioanalyzer

Identifiers

PMID37681892
PMCPMC10486986
OpenAlexW4386220216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.